Impact of medicaid copayments on patients with cancer: Lessons for medicaid expansion under health reform

Medical Care

Volumn 49, Issue 9, 2011, Pages 842-847

  Subramanian, Sujha ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

cost; health reform; low income patients; Medicaid

Indexed keywords

ADULT; ARTICLE; CANCER REGISTRY; COMORBIDITY; EMERGENCY CARE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; COST CONTROL; DEDUCTIBLES AND COINSURANCE; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HUMANS; LEAST-SQUARES ANALYSIS; LOGISTIC MODELS; MALE; MEDICAID; MIDDLE AGED; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES;

EID: 80052148690     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31821b34db     Document Type: Article

References (22)

1. The Henry J. Kaiser Family Foundation-statehealthfacts.org. Available at: http://www.statehealthfacts.org/comparemaptable.jsp?ind=177&cat=4. [Accessed September 4, 2010]
2. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94: 490-496. (Pubitemid 34411287)
3. Du XL, Fang S, Coker AL, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006;106:1276-1285. (Pubitemid 43363904)
4. GAO, Medicaid and SCHIP. States' Premium and Cost Sharing Requirements for Beneficiaries, Report to Congressional Requesters. 2004. Available at: http://www.gao.gov/new.items/d04491.pdf. [Accessed June 5, 2009]
5. Artiga S, O'Malley M. Increasing Premiums and Cost Sharing in Medicaid and SCHIP: Recent State Experiences. Kaiser Commission on Medicaid and the Uninsured. 2005. http://www.kff.org/medicaid/loader. cfm?url=/commonspot/ security/getfile.cfm&PageID=53261 [Accessed on September 4, 2010].
6. Soumerai SB, Avorn J, Ross-Degnan D, et al. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med. 1987;317:550-556. (Pubitemid 17123270)
7. Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drugpayment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:1072-1077.
8. Nelson AA, Reeder CE, Dickson WM. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services. Med Care. 1984;22:724-736.
9. Reeder CE, Nelson AA. The differential impact of copayment on drug use in a Medicaid population. Inquiry. 1985;22:396-403. (Pubitemid 16203270)
10. Stuart B, Zacker C. "Who bears the burden of Medicaid drug copayment policies?" Health Aff (Millwood). 1999;18:201-212.
11. Ku L. "Charging the Poor More for Health Care: Cost-Sharing in Medicaid, Center on Budget and Policy Priorities." 2003. http://www. cbpp.org/cms/index.cfm?fa=view&id=1938 [Accessed on September 4, 2010].
12. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69. (Pubitemid 47026771)
13. Hartung DM, Carlson MJ, Kraemer DF, et al. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Med Care. 2008;46:565-572.
14. Liu SZ, Romeis JC. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Med Care. 2003; 41:1331-1342.
15. Hong SH, Shepherd MD. Outpatient prescription drug use by children enrolled in five drug benefit plans. Clin Ther. 1996;18:528-545. (Pubitemid 26248914)
16. Meissner BL, Moore WM, Shinogle JA, et al. Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids. J Manag Care Pharm. 2004;10:226-233.
17. Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8 suppl):IV-104-IV-117.
18. Charlson ME, Pompei P. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
20. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
21. Norton EC, Wang H, Ai C. Computing interaction effects in logit and probit models. Stata J. 2004;4:154-167.
22. Chartbook: Medicaid Pharmacy Benefit Use and Reimbursement in 2004. Available at: http://www.mathematica mpr.com/publications/PDFs/chartbook2004. pdf. [Accessed January 23, 2011]